An Observational study to assess the Prevalence of Heart Failure in Type 2 Diabetes Patients

Trial Identifier: D1843R00300
Sponsor: AstraZeneca
NCTID:: NCT04072523
Start Date: December 2019
Primary Completion Date: March 2021
Study Completion Date: March 2021
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
India, Delhi Delhi, India, 110085
India, Delhi Delhi, India, 110026
India, Delhi New Delhi, Delhi, India, 110021
India, Gujrat Ahemdabad, Gujrat, India, 380013
India, Gujrat Rajkot, Gujrat, India, 360001
India, Haryana Rohtak, Haryana, India, 124001
India, Karnataka Bangalore, Karnataka, India, 560094
India, Karnataka Bangalore, Karnataka, India, 560043
India, Kerala Kochi, Kerala, India, 682020
India, Maharashtra Mumbai, Maharashtra, India, 400606
India, Maharashtra Mumbai, Maharashtra, India, 400081
India, New Delhi Delhi, New Delhi, India, 110007
India, New Delhi Delhi, New Delhi, India, 110085
India, Punjab Amritsar, Punjab, India, 143001
India, Punjab Chandigarh, Punjab, India, 160011
India, Punjab Jalandhar, Punjab, India, 144001
India, Punjab Ludhiana, Punjab, India, 141001
India, Rajasthan Jodhpur, Rajasthan, India, 342001
India, Tamil Nadu Chennai, Tamil Nadu, India, 600040
India, Tamil Nadu Chennai, Tamil Nadu, India, 600024
India, Telangana Hyderabad, Telangana, India, 500059
India, Telengana Hyderabad, Telengana, India, 500047
India, Uttar Pradesh Kanpur, Uttar Pradesh, India, 208002
India, Uttar Pradesh Kanpur, Uttar Pradesh, India, 208001
India, West Bengal Kolkata, West Bengal, India, 700029
India, West Bengal Kolkata, West Bengal, India, 700050
India, West Bengal Kolkata, West Bengal, India, 700054
India, West Bengal Kolkata, West Bengal, India, 700064
India, West Bengal Kolkata, West Bengal, India, 700019